PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Meta-analysis of animal trials showed significant effects in reducing serum MDA levels and increasing serum SOD and GSH-Px levels [PMID:35564056].
Systematic review indicates significant inhibitory effects on alpha-amylase and alpha-glucosidase, though high heterogeneity exists [PMID:31455758].
Theabrownin from Pu-erh tea reduces hepatic cholesterol and lipogenesis by modulating gut microbiota and bile acid metabolism in mice and humans [PMID:31672964].
Dark tea extract reduced serum transaminase levels and collagen deposition in TAA-induced mice [PMID:40912482].
Pu-erh tea improved obesity in CRD-induced mice via the production of Cinnabarinic acid [PMID:35749873].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31672964 (2019) — Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. · Nature communications
- 2.PMID: 35337597 (2022) — Chemical constituents and biological properties of Pu-erh tea. · Food research international (Ottawa, Ont.)
- 3.PMID: 36875437 (2023) — Dark tea: A popular beverage with possible medicinal application. · Chinese herbal medicines
- 4.PMID: 36910180 (2023) — Reviews of fungi and mycotoxins in Chinese dark tea. · Frontiers in microbiology
- 5.PMID: 35564056 (2022) — Anti-Oxidative Effect of Pu-erh Tea in Animals Trails: A Systematic Review and Meta-Analysis.